Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Medivie Therapeutic

Medivie Therapeutic
2012 FOUNDED
PUBLIC STATUS
MDVI STOCK SYMBOL
2 INVESTMENTS
$4.80 SHARE PRICE (As of Tuesday Closing)
Description

Medivie Therapeutic Ltd. is engaged in the development of dental support devices (DSD) for a variety of medical uses. It currently markets a DSD designed to help deal with the pain of childbirth and to reduce the time spent in labor. This company is also engaged in developing a DSD solution for migraine pain and to improve concentration and cognitive activity.

Website
Formerly Known As
OPRO Mother & Baby
Ownership Status
Publicly Held
Financing Status
Corporation
Primary Industry
Other Healthcare Services
Other Industries
Other Devices and Supplies
Stock Exchange
TAE
Primary Office
  • 1 The Willows
  • Mark Road, Herts
  • Hemel Hempstead HP2 7BN
  • England, United Kingdom

+44 01442 000000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Medivie Therapeutic’s full profile, request a free trial.

Medivie Therapeutic Stock Performance

52 wk Range Market Cap Prev. Close EPS Average Volume Shares
$4.51 - $15.66 $4.85 3.99K
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Medivie Therapeutic Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Medivie Therapeutic‘s full profile, request access.

Request full access to PitchBook

Medivie Therapeutic Acquisitions (2)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
00 000000 01-Nov-2017 000000000000000000 Pharmaceuticals
Glycominds 01-Apr-2014 Merger/Acquisition Diagnostic Equipment
To view this company’s complete investment and acquisition history, request access »

Medivie Therapeutic Exits (1)

Company Name Exit Date Exit Type Exit Size Status Buyers
00 000000 01-Nov-2017 000000000000000000 Completed
  • 0000000 0000000000
To view this company’s complete exits history, request access »

Medivie Therapeutic Investors

Investor Name Investor Type Holding Participating Rounds Investor Since Board Seat Contact Info

This information is reserved for PitchBook Platform users. To explore Medivie Therapeutic‘s full profile, request access.

Request full access to PitchBook

Medivie Therapeutic Executive Team (5)

Name Title Board
Seat
Contact
Info
Shanon Palombo Chief Financial Officer
Roberto Lifschitz Chief Scientist
Anthony Lovat Founder

2 Former Executives

You’re viewing 3 of 5 executives. Get the full list »